Jailendra Singh
Stock Analyst at Truist Securities
(0.48)
# 4,078
Out of 4,975 analysts
183
Total ratings
22.73%
Success rate
-28.03%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $48.41 | -23.57% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $174.88 | +33.81% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $486.07 | -10.30% | 5 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $209 → $235 | $187.68 | +25.21% | 16 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $37.27 | +36.84% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $22.55 | +19.73% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $9.61 | +66.49% | 6 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $69.34 | -12.03% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $55.07 | -12.84% | 1 | Jun 16, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $28.13 | +24.42% | 6 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $7.82 | +15.09% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $23.29 | +20.25% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.00 | +37.50% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $6.98 | +7.45% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $29.71 | +54.83% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $272.93 | -23.06% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $11.46 | +22.16% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $1.20 | +441.67% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.09 | +217.85% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $5.62 | +665.12% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.99 | +501.50% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.07 | +93.24% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $149.56 | -61.22% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $4.80 | +837.50% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $687.40 | -51.56% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.75 | +227.27% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $25.85 | - | 3 | Jan 15, 2021 |
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $48.41
Upside: -23.57%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $174.88
Upside: +33.81%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $486.07
Upside: -10.30%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $209 → $235
Current: $187.68
Upside: +25.21%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $37.27
Upside: +36.84%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $22.55
Upside: +19.73%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $9.61
Upside: +66.49%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $69.34
Upside: -12.03%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $55.07
Upside: -12.84%
Phreesia
May 29, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $28.13
Upside: +24.42%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.82
Upside: +15.09%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $23.29
Upside: +20.25%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.00
Upside: +37.50%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $6.98
Upside: +7.45%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $29.71
Upside: +54.83%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $272.93
Upside: -23.06%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $11.46
Upside: +22.16%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $1.20
Upside: +441.67%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.09
Upside: +217.85%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $5.62
Upside: +665.12%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.99
Upside: +501.50%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.07
Upside: +93.24%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $149.56
Upside: -61.22%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $4.80
Upside: +837.50%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $687.40
Upside: -51.56%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.75
Upside: +227.27%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $25.85
Upside: -